ABT-737 efficiently inhibits hepatocellular carcinoma cell activity via regulating PANoptosis
ABT-737 exerts potent antitumor effects through the induction of PANoptosis in hepatocellular carcinoma, providing a promising therapeutic strategy for HCC treatment.
Authors
- Yunyun Qin
- Bi Deng
- Xuefeng Jin
- Xiaoyu Chen
- Hefang Liu
- Dongmei Ye
Institutions
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1007/s12672-026-04684-z
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00